Page last updated: 2024-11-03

primidone and Basal Ganglia Diseases

primidone has been researched along with Basal Ganglia Diseases in 1 studies

Primidone: A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.
primidone : A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tárczy, M1
Mogyorós, I1
Takáts, A1
Csanda, E1

Other Studies

1 other study available for primidone and Basal Ganglia Diseases

ArticleYear
[Treatment of essential tremor with Sertan].
    Orvosi hetilap, 1983, Apr-03, Volume: 124, Issue:14

    Topics: Age Factors; Aged; Basal Ganglia Diseases; Diagnosis, Differential; Humans; Male; Middle Aged; Parki

1983